The AGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AGEN Detailed Price Forecast - CNN Money||View AGEN Detailed Summary - Google Finance|
|View AGEN Detailed Summary - Yahoo! Finance||View AGEN Stock Research & Analysis - Zacks.com|
|View AGEN Trends & Analysis - Trade-Ideas||View AGEN Major Holders - Barrons|
|View AGEN Call Transcripts - NASDAQ||View AGEN Breaking News & Analysis - Seeking Alpha|
|View AGEN Annual Report - CompanySpotlight.com||View AGEN OTC Short Report - OTCShortReport.com|
|View AGEN Fundamentals - TradeKing||View AGEN SEC Filings - Bar Chart|
|View Historical Prices for AGEN - The WSJ||View Performance/Total Return for AGEN - Morningstar|
|View the Analyst Estimates for AGEN - MarketWatch||View the Earnings History for AGEN - CNBC|
|View the AGEN Earnings - StockMarketWatch||View AGEN Buy or Sell Recommendations - MacroAxis|
|View the AGEN Bullish Patterns - American Bulls||View AGEN Short Pain Metrics - ShortPainBot.com|
|View AGEN Stock Mentions - StockTwits||View AGEN Stock Mentions - PennyStockTweets|
|View AGEN Stock Mentions - Twitter||View AGEN Investment Forum News - Investor Hub|
|View AGEN Stock Mentions - Yahoo! Message Board||View AGEN Stock Mentions - Seeking Alpha|
|View Insider Transactions for AGEN - SECform4.com||View Insider Transactions for AGEN - Insider Cow|
|View AGEN Major Holdings Summary - CNBC||View Insider Disclosure for AGEN - OTC Markets|
|View Insider Transactions for AGEN - Yahoo! Finance||View Institutional Holdings for AGEN - NASDAQ|
|View AGEN Stock Insight & Charts - FinViz.com||View AGEN Investment Charts - StockCharts.com|
|View AGEN Stock Overview & Charts - BarChart||View AGEN User Generated Charts - Trading View|
Agenus Receives Milestone Payment from Incyte
Posted on Monday September 17, 2018
LEXINGTON, Mass., Sept. 17, 2018 /PRNewswire/ -- Agenus Inc. (AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced today receipt of a cash milestone from Incyte for the initiation of a Phase 1 clinical trial of INCAGN2385, an anti-LAG-3 antibody discovered by Agenus. Based on this milestone and under the terms of the agreement, Agenus received a $5 million payment and is eligible to receive up to an additional $505 million in potential development, regulatory and commercial milestones from Incyte. "This is the fourth antibody from our partnered programs that has advanced into clinical trials, once again proving our commitment to deliver on our existing partnerships," said Garo H. Armen, Ph.D., Chairman and CEO of Agenus.
Implied Volatility Surging for Agenus (AGEN) Stock Options
Posted on Friday September 14, 2018
Investors need to pay close attention to Agenus (AGEN) stock based on the movements in the options market lately.
Analysts Still Bullish about BioLife Solutions
Posted on Thursday September 13, 2018
BioLife Solutions (BLFS) generated a net income of $1.05 million in the second quarter compared to a net loss of $768,212 in the second quarter of 2017. That translates to net income per share of $0.05 in the second quarter. Its net loss per share was $0.06 in the second quarter of 2017.
Why Agenus' Stock Perked Up in August
Posted on Friday September 07, 2018
Agenus broke out of its year-long funk last month, but this rally might be short-lived. Here's why.